APA (7th ed.) Citation

Ports, W., Khan, S., Lan, S., Lamba, M., Bolduc, C., Bissonnette, R., & Papp, K. (2013). A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis. British journal of dermatology (1951), 169(1), 137-145. https://doi.org/10.1111/bjd.12266

Chicago Style (17th ed.) Citation

Ports, W.C, S. Khan, S. Lan, M. Lamba, C. Bolduc, R. Bissonnette, and K. Papp. "A Randomized Phase 2a Efficacy and Safety Trial of the Topical Janus Kinase Inhibitor Tofacitinib in the Treatment of Chronic Plaque Psoriasis." British Journal of Dermatology (1951) 169, no. 1 (2013): 137-145. https://doi.org/10.1111/bjd.12266.

MLA (9th ed.) Citation

Ports, W.C, et al. "A Randomized Phase 2a Efficacy and Safety Trial of the Topical Janus Kinase Inhibitor Tofacitinib in the Treatment of Chronic Plaque Psoriasis." British Journal of Dermatology (1951), vol. 169, no. 1, 2013, pp. 137-145, https://doi.org/10.1111/bjd.12266.